摘要 |
<p>Disclosed are ligands that have binding specificity for interleukin-13 (IL-13), or for IL-4 and IL- 13. Also disclosed are methods of using these ligands. In particular, the use of these ligands for treating IL-13-mediated conditions, such as lung conditions, eg allergic asthma, is described. The ligands have potent IL-13 binding kinetics. Ligands are described that are cross-reactive between human IL- 13 and one or more primate IL-13. Ligands are well expressed in prokaryotic cells.</p> |
申请人 |
GLAXO GROUP LIMITED;DOMANTIS LIMITED;DE WILDT, RUDOLF, M, T;DE SILVA, INUSHA;OVECKA, MILAN |
发明人 |
DE WILDT, RUDOLF, M, T;DE SILVA, INUSHA;OVECKA, MILAN |